首页> 美国卫生研究院文献>Cancers >Platelet Proteome and Tumor Dormancy: Can Platelets Content Serve as Predictive Biomarkers for Exit of Tumors from Dormancy?
【2h】

Platelet Proteome and Tumor Dormancy: Can Platelets Content Serve as Predictive Biomarkers for Exit of Tumors from Dormancy?

机译:血小板蛋白质组和肿瘤休眠:血小板含量可以作为预测肿瘤从休眠中退出的标志吗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although tumor dormancy is highly prevalent, the underling mechanisms are still mostly unknown. It is unclear which lesions will progress and become a disseminated cancer, and which will remain dormant and asymptomatic. Yet, an improved ability to predict progression would open the possibility of timely treatment and improvement in outcomes. We have recently described the ability of platelets to selectively uptake angiogenesis regulators very early in tumor growth, and proposed their use as an early marker of malignancy. In this review we will summarize current knowledge about these processes and will discuss the possibility of using platelet content to predict presence of occult tumors.
机译:尽管肿瘤的休眠非常普遍,但其下层机制仍然未知。尚不清楚哪些病变会进展并成为弥漫性癌症,哪些仍处于休眠和无症状状态。然而,提高的预测进展能力将打开及时治疗和改善预后的可能性。我们最近描述了血小板在肿瘤生长的早期非常有选择性地摄取血管生成调节剂的能力,并提出了其作为恶性肿瘤早期标志物的用途。在这篇综述中,我们将总结有关这些过程的最新知识,并讨论使用血小板含量预测隐匿性肿瘤的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号